SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 10/13/05 Curaxis Pharmaceutical Corp S-1/A 9:1.9M RR Donnelley/FA |
Document/Exhibit Description Pages Size 1: S-1/A Amendment No. 1 to Form S-1 HTML 1.21M 2: EX-3.1 Amended and Restated Certificate of Incorporation HTML 68K 3: EX-3.4 Amended and Restated By-Laws HTML 95K 7: EX-10.14 Non-Employee Director Compensation Summary HTML 9K 8: EX-10.15 Executive Officer Compensation Summary HTML 10K 4: EX-10.3 2005 Stock Incentive Plan HTML 54K 5: EX-10.4 Form of Incentive Stock Option Agreement HTML 28K 6: EX-10.5 Form of Nonstatutory Stock Option Agreement HTML 29K 9: EX-23.1 Consent of Pricewaterhousecoopers LLP HTML 6K
CONSENT OF PRICEWATERHOUSECOOPERS LLP |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of our report dated May 4, 2005, except for Note 11, as to which the date is July 15, 2005, relating to the financial statements of Voyager Pharmaceutical Corporation, which appears in such Registration Statement. We also consent to the references to us under the headings “Experts” and “Selected Financial Data” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
This ‘S-1/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 10/13/05 | None on these Dates | ||
10/12/05 | ||||
7/15/05 | ||||
5/4/05 | ||||
List all Filings |